Synthesis of N-substituted ε-hexonolactams as pharmacological chaperones for the treatment of N370S mutant Gaucher disease.
A series of N-substituted ε-hexonolactams have been designed and prepared by a concise route with a tandem ring-expansion reaction as the key step. Some of the N-substituted ε-hexonolactams show better enhancements to N370S mutant β-glucocerebrosidase activity than NB-DNJ and NN-DNJ. Both the experi...
Prif Awduron: | Wang, G, Twigg, G, Butters, T, Zhang, S, Zhang, L, Ye, X |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2012
|
Eitemau Tebyg
-
Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant Gaucher disease.
gan: Wang, G, et al.
Cyhoeddwyd: (2009) -
Amphiphilic 1-deoxynojirimycin derivatives through click strategies for chemical chaperoning in N370S Gaucher cells.
gan: Diot, J, et al.
Cyhoeddwyd: (2011) -
Synthesis of N-alkylated noeurostegines and evaluation of their potential as treatment for Gaucher's disease.
gan: Rasmussen, T, et al.
Cyhoeddwyd: (2011) -
Potent aminocyclitol glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for treating gaucher disease.
gan: Trapero, A, et al.
Cyhoeddwyd: (2012) -
Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease.
gan: Brumshtein, B, et al.
Cyhoeddwyd: (2007)